William J. Regan is SVP & CCO at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB). They have made 3 open-market trades across 1 company since 2013, most recently 2017-06-29.
CIK 0001559381
3 open-market purchases totalling $31K since 2013, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NAVB | 172,977 | $13K |
Shares reported on the most recent Form 4, priced at the 2017-07-03 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.